This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:100 000 INJECTION USP
HOSPIRA HEALTHCARE ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:100 000 INJECTION USP in Canada?
Yes. LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:100 000 INJECTION USP 20MG 10MCG has an active shortage reported to Health Canada (last updated May 11, 2026).
Why is LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:100 000 INJECTION USP not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:100 000 INJECTION USP be available again?
The manufacturer's estimated resolution date is June 15, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
01901915
Strength
20MG 10MCG
Dosage Form
SOLUTION
Route
BLOCK/INFILTRATION
Active Ingredient
LIDOCAINE HYDROCHLORIDE EPINEPHRINE
Tier
Unrated
Last Updated
2019-03-28
Reason for Shortage
Business reasons
Past Reports for This Drug
LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:100 000 INJECTION USP has 3 shortage/discontinuation reports on file — this is one of them.
Other Products from HOSPIRA HEALTHCARE ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.